A suicide Haddon matrix for intervention and prevention to reduce suicide risk

Abstract: Objective: Identifying the individual, environmental, and social characteristics of suicide events is central to developing a comprehensive public health strategy for intervention and prevention of suicide. The Haddon Matrix has previously been used as a tool to address this goal in various forms of injury prevention. The purpose of this paper is to apply the Haddon Matrix to suicide to inform research, prevention, and intervention. Methods: To examine the Haddon Matrix's utility for suicide, a selective literature review was performed of recent and influential papers on risk of suicide across time, identifying contributing factors, conditions, policies, theories, and prevention strategies. Second, the key factors identified were organized on the Haddon Matrix. Third, to examine the pragmatic utility of the Haddon Matrix, the Department of Defense (DoD) Suicide Prevention and Response Independent Review Committee's (SPRIRC) recommendations to prevent military suicides were placed on the Haddon Matrix, and the areas covered were examined. Results: Characteristics of suicide across pre-event, event, and post-event stages were identified at the individual (host), agent (factors related to the method used for suicide), environmental, and social domains. These were used to construct a Suicide Haddon Matrix. Placing the DoD SPRIRC recommendations on the Haddon Matrix showed a concentration of high priority recommendations in the pre-event, host, and agent domains. Conclusion: A Suicide Haddon Matrix can guide researchers, mental health practitioners, and public health officials to key host, agent, physical, and social environment factors. This can identify areas that need research and opportunities for intervention and prevention.

Read the full article
Report a problem with this article

Related articles

  • More for Policy & Practice

    Temporal trends in opioid-related care and pain among Veterans at the end of life

    Abstract: Context: In response to the opioid crisis, federal guidelines were implemented, including the Veterans Health Administration's (VA) Opioid Safety Initiative in 2013. The impact of policies on patients near the end of life is unknown. Objective: Examine temporal trends in opioid prescribing, pain, and opioid overdoses among Veterans near the end of life. Methods: Retrospective, time series analysis of VA decedents between October 2009 and September 2018 whose next-of-kin participated in VA's Bereaved Family Survey (BFS). Using multivariate regression to adjust for sociodemographic and clinical covariates, we examined temporal trends in outpatient opioid prescribing, uncontrolled pain based on BFS report, and opioid overdose-related hospitalizations, in the last month of life, overall and by clinical diagnosis (cancer versus non-cancer). Results: Among 79,409 decedents, mean daily outpatient opioid dose in morphine milligram equivalents in the last month of life decreased from 4.6 mg in 2010 to 2.1 mg in 2018 (adjusted change -0.20 mg/year; P